SEEDPG
TMO icon

S.E.E.D. Planning Group’s Thermo Fisher Scientific TMO Stock Holding History

S.E.E.D. Planning Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.7M Sell
25,830
-377
-1% -$205K 3.69% 9
2025
Q4 		$15.2M Sell
26,207
-1,248
-5% -$706K 4.33% 5
2025
Q3 		$13.3M Sell
27,455
-786
-3% -$366K 3.88% 6
2025
Q2 		$11.5M Buy
28,241
+17,267
+157% +$7.22M 3.59% 10
2025
Q1 		$5.46M Buy
10,974
+348
+3% +$188K 1.84% 25
2024
Q4 		$5.53M Buy
10,626
+618
+6% +$340K 1.85% 19
2024
Q3 		$6.19M Sell
10,008
-127
-1% -$75.2K 2.05% 18
2024
Q2 		$5.6M Sell
10,135
-43
-0.4% -$24.6K 2.04% 20
2024
Q1 		$5.92M Buy
10,178
+371
+4% +$208K 2.16% 19
2023
Q4 		$5.21M Buy
9,807
+503
+5% +$243K 2.1% 18
2023
Q3 		$4.71M Buy
9,304
+302
+3% +$161K 1.82% 23
2023
Q2 		$4.7M Buy
9,002
+198
+2% +$107K 1.65% 28
2023
Q1 		$5.07M Buy
8,804
+855
+11% +$482K 1.96% 21
2022
Q4 		$4.38M Buy
7,949
+1,489
+23% +$789K 1.9% 27
2022
Q3 		$3.28M Buy
6,460
+773
+14% +$433K 1.53% 31
2022
Q2 		$3.09M Buy
5,687
+3,064
+117% +$1.69M 1.4% 33
2022
Q1 		$1.55M Buy
2,623
+27
+1% +$15.5K 0.66% 42
2021
Q4 		$1.73M Sell
2,596
-232
-8% -$145K 0.75% 40
2021
Q3 		$1.62M Sell
2,828
-202
-7% -$111K 0.76% 40
2021
Q2 		$1.53M Buy
3,030
+573
+23% +$270K 0.75% 37
2021
Q1 		$1.12M Buy
+2,457
New +$1.17M 0.62% 39

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

S.E.E.D. Planning Group's TMO Position: Q1 2026 in Review

S.E.E.D. Planning Group reduced its Thermo Fisher Scientific (TMO) stake by 1.4% in Q1 2026, selling an estimated $205K and leaving 25,830 shares worth $12.7M. The position accounts for 3.69% of the portfolio, ranked #9.

S.E.E.D. Planning Group first reported a position in TMO in Q1 2021 and has held it in 21 quarters since. The position peaked at $15.2M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • S.E.E.D. Planning Group held 25,830 shares of Thermo Fisher Scientific worth $12.7M as of Q1 2026.
  • S.E.E.D. Planning Group sold 377 Thermo Fisher Scientific shares in Q1 2026, an estimated $205K.
  • Thermo Fisher Scientific made up 3.69% of S.E.E.D. Planning Group's portfolio in Q1 2026, its #9 holding.
  • S.E.E.D. Planning Group first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 21 quarters since.
  • S.E.E.D. Planning Group's Thermo Fisher Scientific position peaked at $15.2M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on S.E.E.D. Planning Group's 13F filing for Q1 2026, filed 23 Apr 2026.